CSL Launches Annual Scholarship Program
Thirty-seven students receive awards in the first year of a new program for employees and dependents.
Ready to Return to Working On-Sites
Ahead of all employees soon returning to working on-sites, CSL CEO Paul Perreault puts in time at the company’s Pennsylvania …
CSL CEO Paul Perreault on Australia
“It is personal. My headquarters are in Melbourne, I want to get back,” Perreault tells the Australian Financial Review’s BOS…
A Pathway Out of the Pandemic
CSL CEO Paul Perreault talks vaccines, business confidence and innovation at a University of Melbourne event.
Speed Meeting Global Colleagues
In a year with very little business travel, CSL employees found a way to meet across the miles.
CSL CEO Gives Keynote at Patient Event
The company has maintained its focus on patients amid the challenges of the pandemic, CSL Limited CEO Paul Perreault said.
Explainer: What Is PhRMA?
CSL CEO Paul Perreault recently joined the board of the Pharmaceutical Research and Manufacturers of America.
CSL CEO Paul Perreault on Rare Disease Day
See the video Perreault shared with employees: “Reflect on the work we do and the people who count on us to keep innovating.”
Industry Partnership Fuels Research, Advocacy
PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.
CSL CEO at Utah Life Sciences Summit
At biotech event, Paul Perreault will talk about the company’s COVID-19 response – including a potential treatment now in a c…
Three Quotes About an Unprecedented Year
When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.